1 September 2026 - 3 September 2026
Informa Markets,Egypt
Optimizing Order-to-Cash Processes for Greater Efficiency in Pharmaceutical Cold Chain Logistics
The pharmaceutical cold chain has become increasingly complex as biologics, cell and gene therapies, vaccines, and temperature-sensitive specialty medicines make up a larger share of the global market. Because these products require tightly controlled storage, transportation, and handling conditions throughout the supply chain, even minor disruptions can compromise product quality, delay patient access
Why Centrifuge Choice Matters for Cell Separation
Equipment choice in cell separation work dictates viability and yield outcomes. The specifications of a cell separation centrifuge control both the gravitational forces and thermal conditions that biological samples experience during processing. When temperature management falls short or rotational speeds climb too high, researchers risk membrane damage and oxidative stress that compromise sample integrity.
How Better Document Workflows Can Support Pharma Compliance
In pharmaceutical manufacturing, compliance is built on evidence. Every batch record, standard operating procedure, validation report and quality investigation forms part of the documented proof that medicines have been developed and manufactured in accordance with regulatory expectations.
Carrier Scorecards: A Practical Guide for Pharmaceutical Logistics Teams
Pharmaceutical supply chains operate under conditions that leave almost no margin for carrier error. A single temperature excursion can render a shipment unusable. A late delivery to a clinical trial site can delay enrolment. A lost pallet of controlled substances triggers regulatory reporting obligations that consume weeks of compliance work. Against that backdrop, choosing carriers based on rate cards alone is no longer viable, and yet many pharmaceutical logistics teams
Overcoming Supply Chain Bottlenecks with High-Efficiency Single-Use Assembly Solutions
In recent years, the COVID-19 pandemic, geopolitical conflicts and major logistical failures have led to major disruptions in the supply chain. The biopharmaceutical sector, in particular, has felt the impact of these events most sharply, facing exceptional pressure to fast-track vaccine and therapy development within critical timelines.
FUJIFILM Cellular Dynamics Inc. has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in...
Amgen has announced plans to invest an additional US$300 million in its U.S. manufacturing network to expand domestic production capacity, advance nex...
CSL has announced a $1.5 billion expansion of its manufacturing facility in Kankakee, Illinois, to boost production of plasma-derived therapies and al...
AbbVie has announced a $1.4 billion investment to develop a 185-acre pharmaceutical manufacturing campus in Durham. The advanced site will combine mod...
Shamal Fernando
Managing Director at Slim Pharmaceuticals (Pvt) Ltd, SriLanka, Chartered Marketer , Commercial Leader in Healthcare, Professional Trainer, Pharmaceutical Marketer & Leading Pharmaceutical Importer
Slim Pharmaceuticals ( Pvt) Ltd
Innovations in drug discovery processes
Revolutionizing Medicine: Harnessing the Power of AI in Clinical Trials and Quality Management Systems
Addressing challenges in global supply chain logistics.
Exploring Innovations and Opportunities in the EU CMC Market: A Deep Dive into API and FDF Solutions
Bhupinder Singh Interview - CEO at Messe Muenchen India Pvt. Ltd.
Testimonials
Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.
Informa Markets - Asst Exhibition Sales Manager
.
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
-(1).webp)
